CCA Industries (CAW) 3.39 $CAW
CCA Industries Posts Net Revenue Growth For Fiscal 3rd Quarter & First Nine Months of 2014
PR Newswire - Tue Oct 14, 8:16PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
, announced today its third quarter and nine month results for the period ended August 31, 2014. The results can be found on the chart below.
CAW: 3.39 (unch)
Charting a Path to the Future: CCA Industries Announces $6,000,000 Credit Facility; Capital Preservation Holdings LLC Purchase Founder's Class A Shares
PR Newswire - Mon Sep 08, 10:21AM CDT
CCA Industries, Inc. (NYSE MKT: CAW), announced today the following events:
CAW: 3.39 (unch)
CCA Industries divests Mega-T weight loss brand
M2 - Fri Aug 29, 5:17AM CDT
Health & beauty company CCA Industries (NYSE MKT:CAW) announced on Thursday the divestiture of the Mega-T weight loss business brand to a group formed by Casla Partners Capital Fund I.
CAW: 3.39 (unch)
CCA Industries, Inc. Announces The Sale Of Its Mega-T Weight Loss Brand
PR Newswire - Thu Aug 28, 3:30PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW" announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP.
CAW: 3.39 (unch)
CCA Industries, Inc. Reports Second Quarter And First Half Fiscal 2014 Results
PR Newswire - Tue Jul 22, 4:07PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW" , announced today its second quarter and six month results for the period ended May 31, 2014. The results can be found on the chart below.
CAW: 3.39 (unch)
Scar Treatment Market to 2018: Gels, Creams, Oils and Sprays & Invasive Surgical Treatment, Laser Treatment, Elastic Wraps and Gel Sheets
M2 - Wed Jul 16, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4tlhl/global_scar) has announced the addition of the "Global Scar Treatment Market 2014-2018" report to their offering. Scar treatment products are applied on a scar to treat, heal, and conceal the scar. Products such as gels, creams, oils, and sprays are available as OTC products or are prescribed to treat scars. They are an alternative to invasive surgical treatment, laser treatment, elastic wraps, and gel sheets. Scar treatment application products are easy to use and cost-effective in comparison with invasive treatments. The Global Scar Treatment market can be divided into three segments: Burn Scars, Post-surgical Scars Other than Burn Scars, and Others. Burn scars, also known as hypertrophic scars, stay within the area of the original burn. The treatment of post-surgical scars varies with the degree of scarring. The treatment removes the scars caused by minor surgeries such as appendectomy or Caesarean section scars. Some scars can be hypersensitive and decrease ability to move. The Others segment includes scar treatment for aesthetic reasons such as the reduction in the appearance of acne scars. The Global Scar Treatment market is driven by many factors, one of which is an increase in appearance-consciousness among consumers. Scars leave an undesirable mark on the skin, which has a profound impact on the physical and mental well-being of a person. There has been an increase in the desire to maintain flawless skin, which is leading to an increase in the number of personal care and pharmaceutical scar treatment products. The report states that the risk of side effects is one of the major challenges. Scar treatment products may contain harmful chemicals that could cause side effects. Therefore, consumers are more concerned about the ingredients in these products. Some vendors are unable to meet the expectations of customers when it comes to safety standards. Key Vendors - CCA Industries Inc. - Merz Pharmaceuticals GmbH & Co. KGaA - Oculus Innovative Sciences Inc. - Pacific World Corp. Other Prominent Vendors - Avita Medical Ltd. - Enaltus LLC - Quantum Inc. - Revitol Corp. - Scarguard Labs LLC - Valeant Pharmaceuticals International Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c4...lobal_scar
CAW: 3.39 (unch), OCLS: 1.91 (-0.09), VRX.TO: 144.00 (-0.85)
CCA Industries reports departure of two directors
M2 - Tue Jul 08, 5:53AM CDT
Health company CCA Industries (NYSE MKT:CAW) disclosed on Monday the resignation of Sardar Biglari and Dr Philip Cooley as its directors with effect from 1 July 2014.
CAW: 3.39 (unch)
CCA Industries, Inc. Announces Resignation Of Two Directors
PR Newswire - Mon Jul 07, 3:10PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW" announced today the resignation of Sardar Biglari and Dr. Philip Cooley as directors of CCA Industries, Inc. effective July 1, 2014. Mr. Biglari is Chairman and Chief Executive Officer and Dr. Cooley is Vice Chairman of the Board of Biglari Holdings Inc. Mr. Biglari and Dr. Cooley stated in their resignation letters that their resignations were not the result of any disagreements with the Company.
CAW: 3.39 (unch)
CCA Industries, Inc. States That Its Policy Is Not To Comment On Unusual Market Activity
PR Newswire - Mon Jun 23, 4:14PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW" announced today that it has no comment on unusual market activity.
CAW: 3.39 (unch)
CCA Industries, Inc. Reports Fiscal 2013 Results
PR Newswire - Wed Mar 05, 4:08PM CST
CCA Industries, Inc. (NYSE MKT: "CAW" , a manufacturer and marketer of health and beauty aids, announced today its results for the fiscal year ended November 30, 2013. The Company had total revenues for fiscal 2013 of $38,853,387, and a net loss of $6,193,248 as compared to total revenues of $53,775,675 and a net income of $465,452 for fiscal 2012. Basic and fully diluted losses per share were $0.88 for fiscal 2013 as compared to earnings per share of $0.07 for fiscal 2012. Total revenues for the fourth quarter of 2013 were $6,056,615, as compared to $11,373,749 for the fourth quarter of 2012. The net loss for the fourth quarter of 2013 was $4,228,130 as compared to a loss of $352,929 for the fourth quarter of 2012. Basic and fully diluted losses per share were $0.60 for the fourth quarter of 2013 as compared to a loss of $0.05 in the fourth quarter of fiscal 2012. The large loss in the fourth quarter of fiscal 2013 was due to lower sales of the Company's nail color brand and diet brand, combined with higher reserves for returns and inventory related to the nail color brand.
CAW: 3.39 (unch)
Separating Small-Caps by Dividends and Growth
at The Street - Wed Feb 26, 1:00PM CST
Small-caps are having a great run, but some stocks are best for growth exposure while others offer strong dividends.
WFM: 38.03 (+0.37), CAW: 3.39 (unch), UBSI: 32.50 (+0.23), PSEC: 9.64 (-0.03)
IIROC Trading Resumption - RMC
CNW Group - Thu Feb 20, 11:29AM CST
Trading resumes in:
CAW: 3.39 (unch), RMC.VN: 3.870 (+0.110)
AdvisorShares Announces Launch of Four Gold/Currency ETFs (GEUR, GGBP, GYEN, GLDE)
PR Newswire - Tue Feb 11, 7:30AM CST
AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), announced today the launch of four industry-first ETFs - providing gold exposure in different currency terms through a 40 Act structure - which will begin trading on Wednesday, February 12, 2014:
GEUR: 13.06 (-0.23), CAW: 3.39 (unch)
CCA Industries, Inc. Reports Second Quarter Results And Dividend
PR Newswire - Thu Jul 18, 4:09PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW" announced today its results for the second quarter ended May 31, 2013.
CAW: 3.39 (unch)
Soap and Other Detergent Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
M2 - Fri May 31, 9:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/64kjbb/soap_and_other) has announced the addition of Supplier Relations US, LLC's new report "Soap and Other Detergent Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]" to their offering. This 2013 report's 175 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through March 2013. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2017. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report. The industry's revenue for the year 2012 was reported at $33.7 billion USD, with an esti
JNJ: 102.63 (+1.41), CHD: 70.43 (-0.12), IPAR: 27.37 (-0.68), CAW: 3.39 (unch), ZEP: 14.93 (+0.43), SCL: 43.80 (-0.16), ECL: 112.56 (+0.15), CL: 65.05 (-0.27)
CCA Industries, Inc. Reports First Quarter Results
PR Newswire - Wed Apr 17, 3:17PM CDT
CCA Industries, Inc. (NYSE MKT: CAW) announced today its results for the first quarter ended February 28, 2013.
CAW: 3.39 (unch)
CCA Industries, Inc. Reports Year End 2012 Results and Fiscal 2013 First Quarter Dividend
PR Newswire - Thu Mar 07, 3:05PM CST
CCA Industries, Inc. (NYSE MKT: CAW), a manufacturer and marketer of health and beauty aids, announced today its results for the fiscal year ended November 30, 2012. The Company had total revenues for fiscal 2012 of $53,775,675, and net income of $465,452 as compared to total revenues of $49,511,889 and net income of $491,698 for fiscal 2011. Basic and fully diluted earnings per share were $0.07 for both fiscal 2012 and 2011. Total revenues for the fourth quarter of 2012 were $11,373,749, as compared to $11,826,482 for the fourth quarter of 2011. Net loss for the fourth quarter of 2012 was $352,929 as compared to $3,433 for the fourth quarter of 2011. Basic and fully diluted loss per share were $(0.05) for the fourth quarter of 2012 as compared to $(0.00) in the fourth quarter of fiscal 2011.
CAW: 3.39 (unch)
CCA Industries Posts Net Revenue Growth For Fiscal 3rd Quarter & First Nine Months of 2014
PR Newswire - Tue Oct 14, 8:16PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
, announced today its third quarter and nine month results for the period ended August 31, 2014. The results can be found on the chart below. CAW: 3.39 (unch)
Charting a Path to the Future: CCA Industries Announces $6,000,000 Credit Facility; Capital Preservation Holdings LLC Purchase Founder's Class A Shares
PR Newswire - Mon Sep 08, 10:21AM CDT
CCA Industries, Inc. (NYSE MKT: CAW), announced today the following events:
CAW: 3.39 (unch)
CCA Industries divests Mega-T weight loss brand
M2 - Fri Aug 29, 5:17AM CDT
Health & beauty company CCA Industries (NYSE MKT:CAW) announced on Thursday the divestiture of the Mega-T weight loss business brand to a group formed by Casla Partners Capital Fund I.
CAW: 3.39 (unch)
CCA Industries, Inc. Announces The Sale Of Its Mega-T Weight Loss Brand
PR Newswire - Thu Aug 28, 3:30PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP. CAW: 3.39 (unch)
CCA Industries, Inc. Reports Second Quarter And First Half Fiscal 2014 Results
PR Newswire - Tue Jul 22, 4:07PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
, announced today its second quarter and six month results for the period ended May 31, 2014. The results can be found on the chart below. CAW: 3.39 (unch)
Scar Treatment Market to 2018: Gels, Creams, Oils and Sprays & Invasive Surgical Treatment, Laser Treatment, Elastic Wraps and Gel Sheets
M2 - Wed Jul 16, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4tlhl/global_scar) has announced the addition of the "Global Scar Treatment Market 2014-2018" report to their offering. Scar treatment products are applied on a scar to treat, heal, and conceal the scar. Products such as gels, creams, oils, and sprays are available as OTC products or are prescribed to treat scars. They are an alternative to invasive surgical treatment, laser treatment, elastic wraps, and gel sheets. Scar treatment application products are easy to use and cost-effective in comparison with invasive treatments. The Global Scar Treatment market can be divided into three segments: Burn Scars, Post-surgical Scars Other than Burn Scars, and Others. Burn scars, also known as hypertrophic scars, stay within the area of the original burn. The treatment of post-surgical scars varies with the degree of scarring. The treatment removes the scars caused by minor surgeries such as appendectomy or Caesarean section scars. Some scars can be hypersensitive and decrease ability to move. The Others segment includes scar treatment for aesthetic reasons such as the reduction in the appearance of acne scars. The Global Scar Treatment market is driven by many factors, one of which is an increase in appearance-consciousness among consumers. Scars leave an undesirable mark on the skin, which has a profound impact on the physical and mental well-being of a person. There has been an increase in the desire to maintain flawless skin, which is leading to an increase in the number of personal care and pharmaceutical scar treatment products. The report states that the risk of side effects is one of the major challenges. Scar treatment products may contain harmful chemicals that could cause side effects. Therefore, consumers are more concerned about the ingredients in these products. Some vendors are unable to meet the expectations of customers when it comes to safety standards. Key Vendors - CCA Industries Inc. - Merz Pharmaceuticals GmbH & Co. KGaA - Oculus Innovative Sciences Inc. - Pacific World Corp. Other Prominent Vendors - Avita Medical Ltd. - Enaltus LLC - Quantum Inc. - Revitol Corp. - Scarguard Labs LLC - Valeant Pharmaceuticals International Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c4...lobal_scar
CAW: 3.39 (unch), OCLS: 1.91 (-0.09), VRX.TO: 144.00 (-0.85)
CCA Industries reports departure of two directors
M2 - Tue Jul 08, 5:53AM CDT
Health company CCA Industries (NYSE MKT:CAW) disclosed on Monday the resignation of Sardar Biglari and Dr Philip Cooley as its directors with effect from 1 July 2014.
CAW: 3.39 (unch)
CCA Industries, Inc. Announces Resignation Of Two Directors
PR Newswire - Mon Jul 07, 3:10PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
announced today the resignation of Sardar Biglari and Dr. Philip Cooley as directors of CCA Industries, Inc. effective July 1, 2014. Mr. Biglari is Chairman and Chief Executive Officer and Dr. Cooley is Vice Chairman of the Board of Biglari Holdings Inc. Mr. Biglari and Dr. Cooley stated in their resignation letters that their resignations were not the result of any disagreements with the Company. CAW: 3.39 (unch)
CCA Industries, Inc. States That Its Policy Is Not To Comment On Unusual Market Activity
PR Newswire - Mon Jun 23, 4:14PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
announced today that it has no comment on unusual market activity. CAW: 3.39 (unch)
CCA Industries, Inc. Reports Fiscal 2013 Results
PR Newswire - Wed Mar 05, 4:08PM CST
CCA Industries, Inc. (NYSE MKT: "CAW"
, a manufacturer and marketer of health and beauty aids, announced today its results for the fiscal year ended November 30, 2013. The Company had total revenues for fiscal 2013 of $38,853,387, and a net loss of $6,193,248 as compared to total revenues of $53,775,675 and a net income of $465,452 for fiscal 2012. Basic and fully diluted losses per share were $0.88 for fiscal 2013 as compared to earnings per share of $0.07 for fiscal 2012. Total revenues for the fourth quarter of 2013 were $6,056,615, as compared to $11,373,749 for the fourth quarter of 2012. The net loss for the fourth quarter of 2013 was $4,228,130 as compared to a loss of $352,929 for the fourth quarter of 2012. Basic and fully diluted losses per share were $0.60 for the fourth quarter of 2013 as compared to a loss of $0.05 in the fourth quarter of fiscal 2012. The large loss in the fourth quarter of fiscal 2013 was due to lower sales of the Company's nail color brand and diet brand, combined with higher reserves for returns and inventory related to the nail color brand. CAW: 3.39 (unch)
Separating Small-Caps by Dividends and Growth
at The Street - Wed Feb 26, 1:00PM CST
Small-caps are having a great run, but some stocks are best for growth exposure while others offer strong dividends.
WFM: 38.03 (+0.37), CAW: 3.39 (unch), UBSI: 32.50 (+0.23), PSEC: 9.64 (-0.03)
IIROC Trading Resumption - RMC
CNW Group - Thu Feb 20, 11:29AM CST
Trading resumes in:
CAW: 3.39 (unch), RMC.VN: 3.870 (+0.110)
AdvisorShares Announces Launch of Four Gold/Currency ETFs (GEUR, GGBP, GYEN, GLDE)
PR Newswire - Tue Feb 11, 7:30AM CST
AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), announced today the launch of four industry-first ETFs - providing gold exposure in different currency terms through a 40 Act structure - which will begin trading on Wednesday, February 12, 2014:
GEUR: 13.06 (-0.23), CAW: 3.39 (unch)
CCA Industries, Inc. Reports Second Quarter Results And Dividend
PR Newswire - Thu Jul 18, 4:09PM CDT
CCA Industries, Inc. (NYSE MKT: "CAW"
announced today its results for the second quarter ended May 31, 2013. CAW: 3.39 (unch)
Soap and Other Detergent Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]
M2 - Fri May 31, 9:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/64kjbb/soap_and_other) has announced the addition of Supplier Relations US, LLC's new report "Soap and Other Detergent Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]" to their offering. This 2013 report's 175 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through March 2013. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2017. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report. The industry's revenue for the year 2012 was reported at $33.7 billion USD, with an esti
JNJ: 102.63 (+1.41), CHD: 70.43 (-0.12), IPAR: 27.37 (-0.68), CAW: 3.39 (unch), ZEP: 14.93 (+0.43), SCL: 43.80 (-0.16), ECL: 112.56 (+0.15), CL: 65.05 (-0.27)
CCA Industries, Inc. Reports First Quarter Results
PR Newswire - Wed Apr 17, 3:17PM CDT
CCA Industries, Inc. (NYSE MKT: CAW) announced today its results for the first quarter ended February 28, 2013.
CAW: 3.39 (unch)
CCA Industries, Inc. Reports Year End 2012 Results and Fiscal 2013 First Quarter Dividend
PR Newswire - Thu Mar 07, 3:05PM CST
CCA Industries, Inc. (NYSE MKT: CAW), a manufacturer and marketer of health and beauty aids, announced today its results for the fiscal year ended November 30, 2012. The Company had total revenues for fiscal 2012 of $53,775,675, and net income of $465,452 as compared to total revenues of $49,511,889 and net income of $491,698 for fiscal 2011. Basic and fully diluted earnings per share were $0.07 for both fiscal 2012 and 2011. Total revenues for the fourth quarter of 2012 were $11,373,749, as compared to $11,826,482 for the fourth quarter of 2011. Net loss for the fourth quarter of 2012 was $352,929 as compared to $3,433 for the fourth quarter of 2011. Basic and fully diluted loss per share were $(0.05) for the fourth quarter of 2012 as compared to $(0.00) in the fourth quarter of fiscal 2011.
CAW: 3.39 (unch)
